ATTP, the global alliance of national peak professional bodies for commercialisation, industry engagement and entrepreneurship, has a new chair – Dr Tim Boyle, Director of Innovation & Commercialisation at ANSTO.

At ANSTO, Dr Boyle leads nandin, ANSTO’s Innovation Centre and drives strategic initiatives towards challenge based innovation, research commercialisation and economic development.

Announced today at the ATTP Council Global Summit, Dr Boyle succeeds former Chair of three-years, James Zanewicz, Chief Business Officer at Tulane University, Louisiana, USA.

On the appointment, Mr Zanewicz remarked, “I can think of no-one more qualified to assume the position of Chair of ATTP. Dr. Boyle has a truly global perspective on the knowledge transfer profession, and his vision and passion to enhance connectivity and advance global standards are much needed in the world we currently find ourselves in.”

Dr Boyle said he was thrilled about his new appointment and embraced the opportunity to achieve greater positive impact in a “rapidly evolving field with profound changes in government, industry and research due to the COVID-19 pandemic”.

“Given the current unprecedented circumstances, there has never been a better time to be involved in the research commercialisation profession. Our industry is a key enabler of economic development as we transition towards a knowledge-based economy and society is looking towards science and innovation to lead the path to recovery,” he said.

Dr Erin Rayment, Chair of Knowledge Commercialisation Australasia (KCA), said, “It is fantastic to see a fellow KCA board member appointed to this global leadership role. Tim’s appointment shows strong confidence in the Australian approach to research commercialisation. This is important given our local media often incorrectly assumes that we lag behind and underperform in this area.”

“I welcome all the opportunities and challenges that the role of ATTP Chair brings and look forward to working with this rapidly expanding group of professionals. We aim to globally align initiatives to take research to new frontiers of commercialisation and discovery.” Boyle concluded.